A startling opioid crisis discovery at Bowling Green State University has revealed that used drug needles carry far more dangers than most people realise. Scientists found not only a cocktail of unknown substances but also a deadly fungal pathogen. Then they found something that could help fight it.

A Shocking Opioid Crisis Discovery Inside the Needle

A research team led by biological sciences professor Hans Wildschutte Ph.D. worked alongside the Toledo Lucas County Health Department. They analysed needles collected through Northwest Ohio Safe Services, a local needle exchange programme. Their aim was simple: identify the compounds inside the needles and check for non-viral pathogens.

The results were far from simple.

The team found that the average needle contained eight different compounds. Even more alarming, 86% of the needles tested contained xylazine, a powerful animal tranquiliser. That figure suggests xylazine is far more prevalent in the illicit drug supply than health authorities had previously understood.

The most startling find of all, however, was Candida, a dangerous fungal pathogen.

“We thought there was just going to be bacteria in there, so when there was Candida, for me, that was a big surprise,” said Wildschutte.

Why Drug Use Fungal Infection Is So Dangerous

Most people know Candida as the cause of thrush or urinary tract infections. In the context of intravenous drug use, though, it carries a far graver risk. A needle can deliver Candida directly into the bloodstream and trigger a life-threatening blood infection.

Nara Souza, a doctoral student who collaborated on the project, explained why drug use fungal infection creates such a significant challenge for patients and healthcare systems alike.

“We see Candida is already in a lot of hospitals in quite a few states, which is a big concern because we don’t have as many antifungal treatments, especially when compared to antibiotics,” Souza said. “The antifungal medications can have more side effects and can even be toxic to humans, which can limit treatment options. And in addition, the diagnostic testing for fungal infections is more difficult and takes longer.”

A closely related species, Candida auris, sits outside this particular research. But it is multidrug resistant and scientists have already detected it in hospitals across 27 US states.

The Scale of the Problem

This opioid crisis discovery sits against a deeply troubling backdrop. More than 100,000 Americans have died each year since 2021 from causes linked to intravenous drug use. Globally, around two million people die from fungal infections every year, and that number keeps rising.

“There just isn’t a lot of research being done on fungi, but it’s one of the leading causes of infections,” Wildschutte said. “That number is going up because we don’t have a lot of medications with antifungal properties.”

Drug use and fungal infection, this research suggests, are a compounding threat that the medical community has largely overlooked until now.

An Unlikely Ally in the Opioid Crisis Discovery

Here is where the science takes a genuinely unexpected turn. While studying the needles, BGSU researchers came across Pseudomonas, a common soil-based bacterium. Certain strains of Pseudomonas killed Candida outright. That finding could open a new pathway for natural drug discovery.

The team published its findings in the peer-reviewed journal PLOS One.

Graduate student Michael Fyfe said the laboratory work revealed even more promising possibilities. Researchers manipulated Pseudomonas to produce stronger antifungal results.

“We did see some novel interactions that could lead us to some exciting places if we explore this further,” Fyfe said. “There were times that we were able to, in essence, edit the genome to produce more of the antifungal compound.”

Wildschutte shared the same enthusiasm.

“Every time we do these tests, it’s really remarkable that these bacterial strains are able to kill not only these dangerous fungi, but even some multi-drug-resistant pathogens,” he said.

What This Means Going Forward

This opioid crisis discovery matters on two levels. First, it sharpens the picture of hidden risks in intravenous drug use. Users often have no idea what they are injecting, and the threat of drug use fungal infection adds another serious layer of danger.

Second, it offers genuine hope. Pseudomonas could become a natural weapon against Candida, giving clinicians a new option where current treatments are limited and often toxic. More research is needed. But the early findings are, by the scientists’ own words, genuinely exciting.

The dangers of drug use run far deeper than most people understand. Research like this is exactly the kind of work that could change that.

Source: dbrecoveryresources